Publication | Open Access
Self-titration of inhaled corticosteroid and β<sub>2</sub>-agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trial
13
Citations
28
References
2020
Year
The timing of ICS dose when self-titrated to β<sub>2</sub>-agonist use is more important than total ICS dose in reducing severe exacerbation risk in mild asthma, when associated with greater overall use of as-needed β<sub>2</sub>-agonist.
| Year | Citations | |
|---|---|---|
Page 1
Page 1